A 40-year-old Woman with Hypercalcemia Crisis Caused by Bone Metastasis in Stage IV Breast Cancer
Downloads
Breast cancer is still global burden especially for woman with 2.3 million cases every year dan 15% mortality among cancer diseases. In developing countries, most of the cases are diagnosed at terminal stage when metastasis already found. Bone metastasis is the highest among other metastasis sites such as: lung, liver and brain. Bone metastasis will cause hypercalcemia and bone pain as complications. Both will gradually decrease patient's quality of life. Comprehensive and holistic management for these complications will reduce deterioration and hopefully increase patient's quality of life even they were at terminal stage. We describe a 40-year-old woman who got hypercalcemia crisis. Hypercalcemia usually manifest as a consequence of other diseases. Epidemiologically, majority come from metastasis, but can be other diseases, such as multiple myeloma. Interestingly, during medical investigation through her medical history, and physical examination, and laboratory examinations, we conclude that her hypercalcemia crisis was caused by bone metastasis from breast cancer.
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, et al.Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet.2013;9(3): 1-14
Global Burden of Cancer Study, 2020. Global cancer Observatory: Indonesia. Globocan
Chen MT, Sun HF, Zhao Y, Fu WY, Yang LP, Gao SP, Li LD, Jiang HL, Jin W. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Scientific Reports.2017;7(1):9254: 1-8
Shane E, Irani D, 2006. Hypercalcemia: Pathogenesis, clinical manifestations, differential diagnosis, and management. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6, Favus MJ (Ed), American Society for Bone and Mineral Research, Washington, DC
Michels KB, Xue F, Brandt L, et al. Hyperparathyroidism and subsequent incidence of breast cancer. Int J Cancer.2004;110: 449–51
Karim MO, Khan KA, Khan AJ, Javed A, Fazid S, Aslam MI.Triple Assessment of Breast Lump: Should We Perform Core Biopsy for Every Patient? Cureus.2020;12(3):e7479.
Ravi C, Rodrigues G. Accuracy of clinical examination of breast lumps in detecting malignancy: a retrospective study. Indian J Surg Oncol.2012;3(2):154-7
National Cancer Comphrehensive Network.2020. NCNN Clinical Practice Guidelines in oncology (NCNN Guidelines) for Breast Cancer. NCNN Foundation
Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, Bird P, Bourque JM, DeBoer R, Gebrim LH, Masetti R, Masood S, Menon M, Nakigudde G, Ng'ang'a A, Niyonzima N, Rositch AF, Unger-Saldaña K, Villarreal-Garza C, Dvaladze A, El Saghir NS, Gralow JR, Eniu A. Breast cancer treatment: A phased approach to implementation. Cancer.2020;126 (10):2365-78
Irvin W Jr, Muss HB, Mayer DK. Symptom management in metastatic breast cancer. Oncologist.2011;16(9):1203-14
Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X. Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res.2018;10:287-295.
Sigvaldason H, Obayan A, von Kuster K, Pathak KA. Hypercalcemia in metastatic breast cancer unrelated to skeletal metastasis. CMAJ.2016;188(5):E91-E94
Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician.2003;67(9):1959-66.
Crowley R, Gittoes N. How to approach hypercalcaemia. Clin Med (Lond).2013;13(3):287-90
Ziegler R. Hypercalcemic crisis. J Am Soc Nephrol.2011;12(suppl 17):S3-9
LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149(4):259–63
Sternlicht, H., & Glezerman, I. G. (2015). Hypercalcemia of malignancy and new treatment options. Therapeutics and clinical risk management.2015;11:1779–88.
World Health Organization, 2018. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization
Goldvaser H, Amir E. Role of Bisphosphonates in Breast Cancer Therapy. Curr Treat Options Oncol.2019;20(4):26
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).